2018
DOI: 10.1111/ijd.13909
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated actinomycetoma due to Nocardia wallacei

Abstract: Linezolid can be an alternative for the treatment of multidrug resistant Nocardia Wallacei.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…have reported the use of linezolid in the specific management of actinomycotic mycetoma. Welsh et al 10 . reported the successful use of linezolid in the management of disseminated actinomycetoma due to Nocardia wallacei .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…have reported the use of linezolid in the specific management of actinomycotic mycetoma. Welsh et al 10 . reported the successful use of linezolid in the management of disseminated actinomycetoma due to Nocardia wallacei .…”
Section: Discussionmentioning
confidence: 99%
“…Though linezolid has been used successfully in treating disseminated systemic Nocardia infections, there are very few reports regarding the use of linezolid for actinomycetoma (Table 1). 3,[9][10][11] Epelboin et al 9 have reported the use of linezolid in the specific management of actinomycotic mycetoma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2 Mean time in which the lesion healed was three months. Previously, Welsch et al 3 and Epelboin et al 4 have also reported use of linezolid in the specific management of actinomycotic mycetoma.…”
Section: Sirmentioning
confidence: 99%
“…Sensitivity to meropenem must be demonstrated in the laboratory before use [36]. • linezolid has excellent in vitro activity against Nocardia and has been used with success in treatment; therefore linezolid may be used as part of a multi-drug regimen [37,38]. • if the patient has a TMP-SMX allergy desensitisation should be performed if possible.…”
Section: Treatmentmentioning
confidence: 99%